About Ception Therapeutics
Ception Therapeutics is a company based in Malvern (United States) founded in 2004 was acquired by Cephalon in February 2010.. Ception Therapeutics has raised $77.7 million across 2 funding rounds from investors including Cephalon, GreenLight Capital and Growth Capital Fund. Ception Therapeutics offers products and services including Payroll Outsourcing and Payroll Services. Ception Therapeutics operates in a competitive market with competitors including Aclaris Therapeutics, argenx, Escient Pharmaceuticals, MacroGenics and Nimbus Therapeutics, among others.
- Headquarter Malvern, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
- Legal Name Ception Therapeutics, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Ception Therapeutics
Ception Therapeutics offers a comprehensive portfolio of products and services, including Payroll Outsourcing and Payroll Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Service for managing payroll to improve data security and efficiency
Expert solutions for wage and tax handling in businesses
Funding Insights of Ception Therapeutics
Ception Therapeutics has successfully raised a total of $77.7M across 2 strategic funding rounds. The most recent funding activity was a Series C round of $14.7 million completed in May 2007. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series C — $14.7M
-
First Round
First Round
(29 Jan 2007)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2007 | Amount | Series C - Ception Therapeutics | Valuation |
investors |
|
| Jan, 2007 | Amount | Series C - Ception Therapeutics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Ception Therapeutics
Ception Therapeutics has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Cephalon, GreenLight Capital and Growth Capital Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Early, mid, and late-stage investments are made in science sectors.
|
Founded Year | Domain | Location | |
|
A healthcare-focused investment firm supporting innovative company growth.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Ception Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Ception Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Ception Therapeutics Comparisons
Competitors of Ception Therapeutics
Ception Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Aclaris Therapeutics, argenx, Escient Pharmaceuticals, MacroGenics and Nimbus Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel dermatologic therapies are developed for skin conditions.
|
|
| domain | founded_year | HQ Location |
Antibody-based drugs are developed for autoimmune diseases and cancer treatment.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for inflammatory diseases are developed.
|
|
| domain | founded_year | HQ Location |
A biopharmaceutical company focused on cancer therapeutics development.
|
|
| domain | founded_year | HQ Location |
Targeted therapeutics for cancer, metabolic, and inflammatory diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developer of immunotherapies to treat cancer and autoimmune disorders
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Ception Therapeutics
Frequently Asked Questions about Ception Therapeutics
When was Ception Therapeutics founded?
Ception Therapeutics was founded in 2004 and raised its 1st funding round 3 years after it was founded.
Where is Ception Therapeutics located?
Ception Therapeutics is headquartered in Malvern, United States. It is registered at Malvern, Pennsylvania, United States.
Is Ception Therapeutics a funded company?
Ception Therapeutics is a funded company, having raised a total of $77.7M across 2 funding rounds to date. The company's 1st funding round was a Series C of $63M, raised on Jan 29, 2007.
What does Ception Therapeutics do?
Ception Therapeutics was established in 2004 in Malvern, United States, within the biotechnology sector. Focus is placed on discovering, developing, and commercializing treatments for inflammatory conditions. Reslizumab, a monoclonal antibody, is targeted at eosinophilic disorders. Small-molecule Anti-TNF receptor agents, suitable for oral administration, are also pursued. Since February 2010, the entity has functioned as a subsidiary of Cephalon.
Who are the top competitors of Ception Therapeutics?
Ception Therapeutics's top competitors include argenx, Escient Pharmaceuticals and Nimbus Therapeutics.
What products or services does Ception Therapeutics offer?
Ception Therapeutics offers Payroll Outsourcing and Payroll Services.
Who are Ception Therapeutics's investors?
Ception Therapeutics has 6 investors. Key investors include Cephalon, GreenLight Capital, Growth Capital Fund, New Science Ventures, and Aperture Venture Partners.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.